Simplify Logo

Full-Time

Associate Manager of Internal Audit

Confirmed live in the last 24 hours

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Hardware
Biotechnology

Mid, Senior

Somerset County, NJ, USA

Category
Auditing
Accounting
Required Skills
Data Analysis
Requirements
  • Bachelor’s degree from an accredited college / university required
  • Masters, MBA, or CPA, CIA, CISA, CISM strongly preferred
  • Minimum 4 years of experience in auditing (combination of internal and/or external)
  • Experience with Sarbanes-Oxley (SOX) is required
  • Experience in Public Accounting is required
  • Knowledge of U.S. GAAP & IFRS and IIA standards is required
Responsibilities
  • Manage audit risk assessment and develop risk based and value adding audit program via planning and scoping.
  • Manage audit lifecycle from audit planning to audit reporting to meet audit objectives and to ensure compliant, effective and efficient processes and controls are in place:
  • Interview key process owners to assess business processes and the maturity of their control environments.
  • Leverage data analysis in risk assessment and execution of audits.
  • Execute and manage testing procedures that address high risk areas in scope in accordance with Legend Internal Audit and IIA Standards.
  • Identify control gaps, improvement opportunities, and value-added recommendations to strengthen and improve the control environment.
  • Evaluate the risk and potential business impact of identified deficiencies.
  • Document audit workpapers with reperformance standards to include test attributes, associated risks, test conclusions, and opportunities for process improvement.
  • Align audit findings with process owners and operationalize remediation plans.
  • Perform and document walkthroughs and tests of controls to evaluate the effectiveness of the Company’s SOX 404 program.
  • Track identified audit deficiencies/observations and ensure the completion of audit remediations.
  • Collaborate with and help educate process owners on the importance of maintaining strong controls.
  • Build strong relationship with business functions and act as trusted business partner to provide expert insights in the areas of operational audits and SOX audits where the incumbent will review, evaluate and recommend actions to improve control and risk management.
  • Assist department management, including, but not limited to, training and coaching senior and junior auditors. Responsible to prepare evaluations for junior and senior auditor on their projects and will plan an integral part in setting goals and performance objectives.

Legend Biotech develops and sells cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments. Their goal is to provide effective treatments for hard-to-treat diseases through innovative cell therapy solutions.

Company Stage

IPO

Total Funding

$750.5M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

17%

1 year growth

38%

2 year growth

95%
Simplify Jobs

Simplify's Take

What believers are saying

  • Legend Biotech's recent European Commission approval for CARVYKTI® positions it as a leader in the multiple myeloma treatment market.
  • Strategic partnerships, such as the one with MaxCyte, enhance Legend Biotech's capabilities in cell engineering and expand its technological reach.
  • The company's commitment to transparency and investor relations, demonstrated through regular financial updates, fosters investor confidence and long-term stability.

What critics are saying

  • The competitive landscape in cell therapy and personalized medicine is intense, requiring continuous innovation to maintain market position.
  • Regulatory hurdles and the need for extensive clinical trials can delay the commercialization of new therapies, impacting revenue streams.

What makes Legend Biotech unique

  • Legend Biotech's technology-agnostic approach allows it to explore multiple innovative therapies, unlike competitors who may focus on a single technology.
  • The company's comprehensive business model, from discovery to commercialization, ensures control over the entire treatment lifecycle, providing a competitive edge.
  • Legend Biotech's strong focus on CAR-T therapies, particularly for hematological malignancies and solid tumors, sets it apart in the personalized medicine sector.